In addition to the expression of IMP3, tumor multiplicity is also a risk factor affecting disease-free survival, and tumor stage T1 (relative to stage Ta) is an unfavorable prognostic factor of progression-free survival and metastasis-free survival. Here, IMP3 is linked to neoplasm.